N Engl J Med 380(24):22952306 Kristensen SL, Rrth R, Jhund PS, Docherty KF, Sattar N, Preiss D et al (2019) Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Yes, peptides can be used alongside other treatments like physical therapy, chiropractic care, and even pain medications
This blog post takes a deep dive into what this means for patients, separating fact from fear, and helping you understand how to balance the benefits and risks of GLP-1 therapy
However, the children's pediatricians confirmed exclusion and inclusion criteria by completing the Pediatrician Form, which also provided details of general health and previous medical history and recommendation for participation in the trial
Because Mounjaro already provides potent incretin-based glucose control, adding Januviawhich works by preserving naturally occurring incretinsoffers little to no added benefit